This Article Free upon publication Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Tomaselli, G. F. Search for Related Content PubMed PubMed Citation Articles by Tomaselli, G. F. Related Collections Clinical genetics Arrythmias-basic studies Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2007;115:428-429.)
© 2007 American Heart Association, Inc.

Editorial

A Failure to Adapt

Ankyrins in Congenital and Acquired Arrhythmias

Gordon F. Tomaselli, MD

From Johns Hopkins University, Department of Medicine, Division of Cardiology, Baltimore, Md.

Correspondence to Gordon F. Tomaselli, MD, David J. Carver Professor of Medicine, 720 N Rutland Ave, Ross 844, Johns Hopkins University, Baltimore, MD 21205. E-mail gtomasel@jhmi.edu

Key Words: Editorials • arrhythmia • death, sudden • electrophysiology • genes • long-QT syndrome • torsade de pointes

An extract of the first 250 words of the full text is provided, because this article has no abstract.

The development of serious, potentially lethal cardiac arrhythmias is determined by a complex integration of factors, including, but not limited to, common and rare genetic variants that determine the responses to gene-gene and gene-environment interactions. Even the rare "simple" channelopathies that cause long-QT syndrome (LQTS) and a host of other potentially lethal arrhythmias exhibit a complex set of phenotypes of varying severity and overlapping features. Ankyrins are a family of adapter proteins, first identified in the erythrocyte membrane, that mediate the localization of a diverse group of cellular proteins. Three genes in the mammalian genome encode ankyrins that share a similar global architecture but exhibit distinct expression patterns and functions: ANK1 encodes ankyrin-R, which exhibits a more restricted expression; ANK2 (chromosome 4q25–27) encodes the more broadly distributed ankyrin-B; and ANK3 encodes the ankyrin-G for general or global. Ankyrins bind a number of ion motive proteins essential to normal cardiac electrophysiology, including the Na⁺-Ca²⁺ exchanger; inositol 1,4,5-triphosphate receptor; Na⁺-K⁺ ATPase; and the voltage-dependent sodium channel (Na_V1.5) By the very nature of the role of ankyrins in excitation and contraction in cardiac myocytes, it is understandable that variants in ankyrin-B originally described in a family with congenital LQTS¹ would exhibit protean electrical phenotypes. Indeed, in the original LQTS cohort, sinus node dysfunction and atrial fibrillation have been described,^1,2 and other electrophysiological abnormalities such as conduction block, idiopathic ventricular fibrillation, and catecholaminergic ventricular tachycardia have been included under the rubric of ankyrin-B syndrome.³ A mutation in the ankyrin binding domain . . . [Full Text of this Article]